A Phase 2A, Randomized, Double-Blind, Placebo Controlled Study Investigating The Safety Of Ritlecitinib (Pf-06651600) In Adult Participants With Alopecia Areata

Last Updated:
01/20/2021
Status:
Recruiting
Country:
United States
Eligibility:
Ages 18-50; diagnosed with alopecia areata (at least 25% hair loss due to AA)
Drug:
PF-06651600
Administration:
Oral
Sponsor: 
Pfizer

A clinical research study is currently looking for adults with alopecia areata who have lost 25% or more of the hair on their head to participate in a study of an oral investigational medication. The study will explore whether the study drug is safe and can help patients with alopecia areata regrow their hair.

The study will run for approximately 26 months. This includes up to a 5-week screening period, a 9-month treatment period where the investigational medication is compared to an inactive placebo, a 15-month treatment period where all study participants take the investigational medication, plus a 4-week follow-up period.

You may qualify to participate if you:

  • are 18-50 years of age
  • have been diagnosed with alopecia areata
  • have at least 25% scalp hair loss*
*study doctor will assess your amount of hair loss.

If you or someone you know is interested in joining this clinical trial, please contact the most convenient trial site listed below for more information:

Marvel Clinical Research
Huntington Beach, CA
Contact: David Wilson
Phone: 520-241-9435

University of California, Irvine
Irvine, CA
Contact: Melissa Orr
Phone: 949-824-7103

Stanford University School of Medicine
Palo Alto, CA
Contact: Elidia Tafoya
Phone: 650-724-1982

Skin Care Research, LLC
Boca Raton, FL
Contact: Angela Garcia
Phone: 561-948-3116

Skin Care Research, LLC
Hollywood, FL
Contact: Angela Garcia
Phone: 954-674-3535

CNS Healthcare
Jacksonville, FL
Contact: Niketa Kamble
Phone: 904-281-5757

Elite Clinical Research
Miami, FL
Contact: Nuvia Herrera
Phone: 305-262-3396

CNS Healthcare
Orlando, FL
Contact: Joan Cutillo
Phone: 407-425-5100

BRCR Medical Center Inc.
Plantation, FL
Contact: Ines Padron
Phone: 561-447-0614

Morsani College of Medicine
Tampa, FL
Contact: Dusan Nikolic-Dorschel
Phone: 813-493-3034

NorthShore University Health System
Skokie, IL
Contact: Cherlyn Cagadas
Phone: 847-663-8530

Washington University School of Medicine
St. Louis, MO
Contact: Justin Stout
Phone: 314-273-1376

Stony Brook University
Stony Brook, NY
Contact: Jennifer Intravaia
Phone: 631-638-2328

M3 Wake Research
Raleigh, NC
Contact: Brian Joseph
Phone: 858-987-2219

CNS Healthcare
Memphis, TN
Contact: Courtney Hale
Phone: 407-697-2779

Tekton Research
Austin, TX
Contact: Steffanie Mott
Phone: 512-388-5717

Center for Clinical Studies
Houston, TX
Contact: Mario Guerrero
Phone: 713-528-8818 Ext. 1203

Education & Research Foundation
Lynchburg, VA
Contact: Sue Foster
Phone: 434-847-8400 Ext. 1103

Virginia Dermatology & Skin Cancer Center
Norfolk, VA
Contact: Samantha Wilson
Phone: 757-653-1379